[EDRM is proud to support our Trusted Partner, Cellebrite, on the announcement of their planned acquisition.]
Adding an open-source intelligence solution to its DI offering strategically positions Cellebrite to expand its work within law enforcement intelligence and investigation efforts
Petah Tikvah, Israel, October 11, 2021: Cellebrite (Nasdaq: CLBT), a leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced it has signed a definitive agreement to acquire the assets of open-source intelligence firm Digital Clues AG (“Digital Clues”).
Open-source intelligence capabilities provide law enforcement agencies with critical tools to capitalize on those crucial early hours of an investigation. The team at Digital Clues has built up a strong reputation in this space and we look forward to welcoming them into the Cellebrite family.
Yossi Carmil, Cellebrite CEO
The acquisition strengthens Cellebrite’s market-leading Digital Intelligence platform, reinforces our position as the end-to-end technology partner capable of digitizing the entire investigative workflow, and is expected to aid in growing the company’s footprint within law enforcement intelligence and investigation units across the globe.
The start of an investigation is time-sensitive, and information must be gathered as quickly as possible. Digital Clues’ open-source intelligence solutions kickstart law enforcement intelligence and investigation efforts when there are no targets and very few clues, helping customers collect and connect data from many dynamic sources including the surface web, deep web, and dark web.
Israel-based Digital Clues has a team of more than 20 persons, boasting a strong contingent of Research & Development specialists and a leadership team with decades of experience across intelligence, big data, and security for public safety agencies and enterprises. Digital Clues technology is available both as a SaaS offering and as on-premise software. Their solutions enable the collection of large amounts of data from various sources, leveraging artificial intelligence to draw valuable insights on suspected persons or entities while enriching other digital evidence with valuable information from open sources.
Yossi Carmil, Cellebrite CEO, said “we are pleased to announce this acquisition, an important step in executing against our vision of building a leading end-to-end investigative Digital Intelligence platform. Open-source intelligence capabilities provide law enforcement agencies with critical tools to capitalize on those crucial early hours of an investigation. The team at Digital Clues has built up a strong reputation in this space and we look forward to welcoming them into the Cellebrite family.”
Yossi Ofek, CEO & Chairman of Digital Clues, brings over 20 years of experience in homeland security and will lead the open-source intelligence business efforts at Cellebrite. He comments: “The demand for cloud-based and on-premises open-source intelligence solutions is driven by the increasing need for automated systems to help public safety agencies sift through the tidal wave of information hosted on the web. We share Cellebrite’s commitment to accelerate justice and are excited about combining Digital Clues’ capabilities with Cellebrite’s world-leading and comprehensive Digital Intelligence platform.”
The acquisition is expected to close in the fourth quarter of 2021 and is subject to customary closing conditions.
About Cellebrite
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. Cellebrite is the global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations to master the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies in more than 140 countries, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com and https://investors.cellebrite.com.
Caution Regarding Forward-Looking Statements
This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of the business of Cellebrite are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to develop technologically advanced solutions and successfully integrate with the software solutions used by customers; acceptance of solutions by customers; errors, failures, defects or bugs in solutions; a failure to maintain sales and marketing personnel productivity or hire, integrate and retain additional sales and marketing personnel; the impact of the global COVID-19 pandemic; the impact of competition on pricing and on Cellebrite’s market share; sub-optimal results from products due to misuse by customers; Cellebrite’s failure to maintain and enhance its reputation and brand; inaccuracy of the estimates of Cellebrite’s market opportunity and forecasts of market growth; changes to packaging and licensing models that adversely affect the ability to attract or retain customers; failure to manage future growth effectively; failure to introduce new solutions and add-ons; issues in the use of artificial intelligence resulting in reputational harm or liability; the need for additional capital to support the growth of Cellebrite’s business; a failure to maintain the security of operations and the integrity of software solutions; the impact of government budgeting cycles and appropriations, early termination, audits, investigations, sanctions and penalties; a decline in government budgets, changes in spending or budgetary priorities, or delays in contract awards; a failure to adequately obtain, maintain, protect and enforce Cellebrite’s intellectual property or infringement of the intellectual property rights of others; perceptions or court or regulatory decisions that Cellebrite’s solutions violate privacy rights; the use of solutions by customers in a way that is, or that is perceived to be, incompatible with human rights; failure to comply with laws regarding privacy, data protection and security, technology protection, sanctions, export controls and other matters; and other factors, risks and uncertainties set forth in the sections titled “Risk Factors” and “Cautionary Note Regarding Forward-Looking Statements” in the final proxy statement/prospectus relating to Cellebrite’s consummated business combination filed with the SEC on August 5, 2021 and in other documents filed by Cellebrite with the SEC, which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments, or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Media
Adam Jaffe
VP of Global Communications
+1 973 206 7643
adam.jaffe@cellebrite.com – or –
RapidResponse@cellebrite.com
Investors
Anat Earon-Heilborn
VP Investor Relations
+972 73 394 8440
investors@cellebrite.com
